Published in Pain on January 20, 2012
A cross-sectional study on prevalence of pain and breakthrough pain among an unselected group of outpatients in a tertiary cancer clinic. Support Care Cancer (2014) 1.97
Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction. Drug Des Devel Ther (2015) 0.83
Is it possible to detect an improvement in cancer pain management? A comparison of two Norwegian cross-sectional studies conducted 5 years apart. Support Care Cancer (2015) 0.81
Characteristics and associations of pain intensity in patients referred to a specialist cancer pain clinic. Pain Res Manag (2015) 0.80
The challenges of prognosis in cancer pain. Pain (2012) 0.75
Cancer pain undertreatment and prognostic factors. Pain (2012) 0.75
Characteristics and prognostic factors for pain management in 152 patients with lung cancer. Patient Prefer Adherence (2016) 0.75
Definition and classification of cancer cachexia: an international consensus. Lancet Oncol (2011) 7.78
High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med (2005) 7.20
Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res (2004) 4.33
Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214). J Clin Oncol (2011) 3.56
Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage (2011) 3.44
Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol (2012) 3.26
Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol (2005) 2.76
Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up. J Clin Oncol (2002) 2.65
Smoking in Italy 2005-2006: effects of a comprehensive National Tobacco Regulation. Prev Med (2007) 2.61
Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies. Blood (2012) 2.51
Randomized phase III study comparing paclitaxel-bleomycin, etoposide, and cisplatin (BEP) to standard BEP in intermediate-prognosis germ-cell cancer: intergroup study EORTC 30983. J Clin Oncol (2012) 2.36
Opioid purchases and expenditure in nine western European countries: 'are we killing off morphine?'. Palliat Med (2005) 2.32
The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors. Palliat Med (2003) 2.18
Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol (2003) 2.09
Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care. Cancer (2002) 2.01
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale. J Peripher Nerv Syst (2007) 2.01
The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain (2005) 2.00
The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer (2005) 1.97
A cross-sectional study on prevalence of pain and breakthrough pain among an unselected group of outpatients in a tertiary cancer clinic. Support Care Cancer (2014) 1.97
Tidsskr Nor Laegeforen (2016) 1.94
Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol (2009) 1.93
Estimating the prevalence of chronic pain: validation of recall against longitudinal reporting (the HUNT pain study). Pain (2012) 1.92
The effect of a physical exercise program in palliative care: A phase II study. J Pain Symptom Manage (2006) 1.92
Pain measurement tools and methods in clinical research in palliative care: recommendations of an Expert Working Group of the European Association of Palliative Care. J Pain Symptom Manage (2002) 1.91
Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial. J Clin Oncol (2004) 1.85
Pain and pain treatments in European palliative care units. A cross sectional survey from the European Association for Palliative Care Research Network. Palliat Med (2005) 1.75
A Wireless Health Outcomes Monitoring System (WHOMS): development and field testing with cancer patients using mobile phones. BMC Med Inform Decis Mak (2004) 1.72
Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain (2006) 1.72
Assessment and classification of cancer breakthrough pain: a systematic literature review. Pain (2010) 1.70
Associations between recreational exercise and chronic pain in the general population: evidence from the HUNT 3 study. Pain (2011) 1.70
Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy. Am J Epidemiol (2012) 1.68
Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study. J Clin Oncol (2011) 1.61
Pain assessment tools: is the content appropriate for use in palliative care? J Pain Symptom Manage (2006) 1.61
Which patients with cancer die at home? A study of six European countries using death certificate data. J Clin Oncol (2010) 1.58
MATILDE chemotherapy regimen for primary CNS lymphoma: results at a median follow-up of 12 years. Neurology (2014) 1.58
The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients. J Pain Symptom Manage (2002) 1.58
Eliciting individual preferences about death: development of the End-of-Life Preferences Interview. J Pain Symptom Manage (2008) 1.57
Psychosocial effects of cancer cachexia: a systematic literature search and qualitative analysis. J Pain Symptom Manage (2012) 1.50
Non-steroidal anti-inflammatory treatment in cancer cachexia: a systematic literature review. Acta Oncol (2012) 1.49
The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up. Lung Cancer (2003) 1.47
Update on cancer pain guidelines. J Pain Symptom Manage (2009) 1.46
Edmonton symptom assessment scale: Italian validation in two palliative care settings. Support Care Cancer (2005) 1.43
A prospective study on survival in cancer patients with and without venous thromboembolism. Intern Emerg Med (2013) 1.42
Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain. Mol Pain (2008) 1.41
Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol Hematol (2011) 1.41
Further restrictions for ICU research. Intensive Care Med (2005) 1.40
Metabolic syndrome and health-related quality of life: does psychological well-being matter? Ann Epidemiol (2008) 1.40
[Does use of alternative medicine aggravate the survival prognosis in cancer?]. Tidsskr Nor Laegeforen (2003) 1.40
[71-year old man with severe circulatory collapse following heart arrest]. Tidsskr Nor Laegeforen (2010) 1.39
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy. Intern Emerg Med (2014) 1.38
Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study. J Clin Oncol (2010) 1.36
Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health Qual Life Outcomes (2010) 1.34
Reduced mortality in treating acutely sick, frail older patients in a geriatric evaluation and management unit. A prospective randomized trial. J Am Geriatr Soc (2002) 1.33
Dying with advanced dementia in long-term care geriatric institutions: a retrospective study. J Palliat Med (2008) 1.33
Breakthrough cancer pain: an observational study of 1000 European oncology patients. J Pain Symptom Manage (2013) 1.32
Using death certificate data to study place of death in 9 European countries: opportunities and weaknesses. BMC Public Health (2007) 1.31
Antiplatelet effect of clopidogrel is reduced in patients treated with therapeutic hypothermia after cardiac arrest. Resuscitation (2010) 1.29
Prevalence, incidence and types of mild anemia in the elderly: the "Health and Anemia" population-based study. Haematologica (2010) 1.28
Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine. Eur J Cancer (2005) 1.25
Assessment and classification of cancer pain. Curr Opin Support Palliat Care (2009) 1.25
Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review. Pain (2011) 1.22
Physical exercise for cancer patients with advanced disease: a randomized controlled trial. Oncologist (2011) 1.21
Cancer patients' needs during hospitalisation: a quantitative and qualitative study. BMC Cancer (2003) 1.20
Family satisfaction with end-of-life care for cancer patients in a cluster randomized trial. J Pain Symptom Manage (2002) 1.20
A framework for generalizability in palliative care. J Pain Symptom Manage (2008) 1.17
Association of mild anemia with cognitive, functional, mood and quality of life outcomes in the elderly: the "Health and Anemia" study. PLoS One (2008) 1.15
Can rituximab change the usually dismal prognosis of patients with intravascular large B-cell lymphoma? J Clin Oncol (2008) 1.15
Association of mild anemia with hospitalization and mortality in the elderly: the Health and Anemia population-based study. Haematologica (2008) 1.14
Nutritional status of patients with advanced cancer: the value of using the subjective global assessment of nutritional status as a screening tool. Palliat Med (2002) 1.14
Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy. Eur J Cancer (2010) 1.13
Fatigue in palliative care patients -- an EAPC approach. Palliat Med (2008) 1.12
Quality of life in breast and colon cancer long-term survivors: an assessment with the EORTC QLQ-C30 and SF-36 questionnaires. Tumori (2002) 1.11
Assessing physical functioning: a systematic review of quality of life measures developed for use in palliative care. Palliat Med (2007) 1.10
Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review. Palliat Med (2011) 1.10
Evolving classification systems for cancer cachexia: ready for clinical practice? Support Care Cancer (2010) 1.10
Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system. Clin Cancer Res (2013) 1.09
A classification of chronic pain for ICD-11. Pain (2015) 1.09